V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002298 | 210008230 | null | 98.6 | Adjuvant (A) | 2017-08-22 | 2017-11-08 | Docetaxel | 2 | N | DOCETAXEL | 101783298 |
| 210002307 | 210008232 | 1.74 | 79.8 | null | 2016-07-11 | 2016-09-12 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100344776 |
| 210002308 | 210008233 | 1.59 | 91.7 | Adjuvant (A) | 2018-07-20 | 2018-12-16 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101531795 |
| 210002310 | 210008235 | 1.58 | 86.9 | Adjuvant (A) | 2019-12-07 | 2020-03-01 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100937309 |
| 210002311 | 210008236 | 1.75 | 73.5 | Palliative (P) | 2019-06-19 | 2019-09-11 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100874153 |
| 210002316 | 210008239 | 1.48 | 160 | Adjuvant (A) | 2019-02-16 | 2019-07-26 | TRASTUZUMAB | null | N | TRASTUZUMAB | 100384883 |
| 210002321 | 210008242 | 1.69 | 46.55 | Neo-adjuvant (N) | null | 2021-01-12 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100665242 |
| 210002322 | 210008243 | 1.58 | 57.7 | Adjuvant (A) | null | 2018-11-23 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101482528 |
| 210002326 | 210008247 | 1.54 | 87.3 | Adjuvant (A) | 2017-03-27 | 2017-03-28 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100710065 |
| 210002327 | 210008248 | null | 78.3 | Neo-adjuvant (N) | null | 2018-01-13 | Docetaxel | null | N | DOCETAXEL | 100688724 |
| 210002329 | 210008249 | 1.65 | 57 | Adjuvant (A) | 2016-03-23 | 2016-06-27 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101024370 |
| 210002330 | 210008250 | 1.58 | 63.6 | Adjuvant (A) | 2019-07-13 | 2019-10-12 | Paclitaxel 7 day | null | N | PACLITAXEL | 100871801 |
| 210002332 | 210008251 | 1.61 | 48.9 | Neo-adjuvant (N) | null | 2017-12-28 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100029914 |
| 210002333 | 210008252 | 1.65 | 82 | Palliative (P) | 2017-04-13 | 2017-06-11 | Docetaxel | 02 | N | DOCETAXEL | 100259113 |
| 210002334 | 210008253 | 1.63 | 76.1 | Adjuvant (A) | null | 2017-03-07 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 100728878 |
| 210002335 | 210008254 | 1.64 | 111.3 | Adjuvant (A) | null | 2017-09-24 | PACLITAXEL | 02 | N | PACLITAXEL | 101185242 |
| 210002337 | 210008255 | null | 85.8 | Adjuvant (A) | 2020-05-09 | 2020-05-23 | Trastuzumab | 2 | null | TRASTUZUMAB | 101780891 |
| 210002338 | 210008256 | null | 64.3 | Adjuvant (A) | 2017-07-12 | 2018-06-06 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101336056 |
| 210002340 | 210008257 | 1.62 | 82 | Neo-adjuvant (N) | null | 2018-12-19 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101000180 |
| 210002343 | 210008260 | null | 65.7 | Palliative (P) | 2018-03-31 | 2018-06-10 | Docetaxel | 02 | N | DOCETAXEL | 100353858 |
| 210002344 | 210008261 | 1.66 | 74 | Adjuvant (A) | 2018-03-10 | 2018-06-13 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100834406 |
| 210002345 | 210008262 | 1.55 | 80.8 | Adjuvant (A) | null | 2017-01-26 | Docetaxel | 02 | N | DOCETAXEL | 100080358 |
| 210002346 | 210008263 | 1.61 | 59 | null | 2016-12-17 | 2018-01-06 | Trastuzumab 21 day maintenance | 02 | Y | TRASTUZUMAB | 100302717 |
| 210002348 | 210008264 | 1.58 | 68.7 | Adjuvant (A) | null | 2019-04-28 | Docetaxel | 02 | N | DOCETAXEL | 101239949 |
| 210002350 | 210008265 | 1.69 | 77 | Palliative (P) | null | 2021-11-26 | Docetaxel | 02 | N | DOCETAXEL | 100795840 |
| 210002351 | 210008266 | 1.51 | 76.6 | Adjuvant (A) | 2020-08-20 | 2020-09-23 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101653611 |
| 210002352 | 210008267 | null | 75 | null | 2016-08-19 | 2016-10-27 | PACLITAXEL | 02 | null | PACLITAXEL | 100828899 |
| 210002353 | 210008268 | 1.6 | 79.7 | Palliative (P) | 2018-07-30 | 2018-11-06 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100062282 |
| 210002355 | 210008269 | 1.6 | 85.5 | Adjuvant (A) | null | 2018-10-24 | Paclitaxel (2 or 3 weekly) | null | N | PACLITAXEL | 100617399 |
| 210002356 | 210008270 | 1.7 | 76.1 | Adjuvant (A) | 2019-09-14 | 2020-02-09 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100612832 |
| 210002358 | 210008272 | 1.67 | 54 | null | 2013-02-02 | 2013-06-17 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100651139 |
| 210002360 | 210008274 | 1.65 | 75.5 | Adjuvant (A) | null | 2018-07-14 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100012837 |
| 210002363 | 210008275 | 1.6 | 93 | Adjuvant (A) | null | 2018-10-03 | Trastuzumab Subcutaneous | N | N | TRASTUZUMAB | 101304943 |
| 210002364 | 210008276 | 1.66 | 106.4 | Neo-adjuvant (N) | 2018-03-22 | 2018-03-29 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100020222 |
| 210002368 | 210008278 | null | 65 | Palliative (P) | 2018-08-08 | 2018-11-19 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100260920 |
| 210002370 | 210008280 | 1.6 | 93.5 | null | 2019-02-05 | 2019-05-21 | PACLITAXEL | null | N | PACLITAXEL | 101351694 |
| 210002371 | 210008281 | 1.65 | 50.4 | null | 2018-05-06 | 2019-03-26 | PACLITAXEL | 02 | N | PACLITAXEL | 100618231 |
| 210002372 | 210008282 | 1.65 | 70.6 | Adjuvant (A) | null | 2019-02-17 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101701087 |
| 210002374 | 210008284 | 1.66 | 0 | Adjuvant (A) | 2018-02-25 | 2018-05-31 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100655188 |
| 210002375 | 210008285 | 1.58 | 65.2 | Adjuvant (A) | null | 2017-07-08 | Docetaxel 75mg/m2 (21 day) | null | N | DOCETAXEL | 100472584 |
| 210002378 | 210008286 | 1.75 | 81.4 | Adjuvant (A) | null | 2017-11-17 | Docetaxel | 02 | N | DOCETAXEL | 101606560 |
| 210002380 | 210008288 | 1.52 | 61.1 | null | 2014-10-13 | 2017-01-28 | Trastuzumab | 02 | null | TRASTUZUMAB | 100529435 |
| 210002381 | 210008289 | 1.57 | 73.5 | Adjuvant (A) | null | 2019-05-12 | Trastuzumab Subcutaneous | null | Y | TRASTUZUMAB | 101499226 |
| 210002384 | 210008290 | null | null | Neo-adjuvant (N) | 2016-06-01 | 2020-10-30 | Paclitaxel 7 day | null | N | PACLITAXEL | 100493145 |
| 210002390 | 210008293 | 1.59 | 77 | Adjuvant (A) | null | 2019-04-29 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100896205 |
| 210002392 | 210008295 | 1.6 | 100 | null | 2019-06-08 | 2019-06-10 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100659269 |
| 210002395 | 210008296 | null | 56.5 | null | null | 2019-11-07 | Docetaxel | null | null | DOCETAXEL | 100393824 |
| 210002399 | 210008298 | 1.69 | null | Palliative (P) | 2021-06-29 | 2021-11-13 | Docetaxel | 02 | N | DOCETAXEL | 101369637 |
| 210002402 | 210008299 | null | 92.5 | Adjuvant (A) | 2019-01-18 | 2019-06-24 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100907387 |
| 210002406 | 210008303 | 0 | 60.2 | Adjuvant (A) | null | 2016-04-10 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101482356 |